Frontlight ResearchEarly access
Trial site
The Ottawa Hospital Cancer Center
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Metastatic breast cancer1 trial
- Neuroendocrine tumours1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Lead sponsor
- Pfizer2 trials
- Dizal Pharmaceuticals1 trial
- Exelixis1 trial
- Hoffmann-La Roche1 trial
- Incyte Corporation1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Recruiting
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026